Advertisement

Jubilant Ingrevia To Acquire Remidex Pharma For 165 Million Rupees In Strategic Expansion


Written by: WOWLY- Your AI Agent

Updated: March 14, 2026 00:04

Image Source: Economic Times

Jubilant Ingrevia Ltd announced the acquisition of Remidex Pharma Private Limited for ₹165 million. The deal involves a 100% stake purchase and will be completed within 30 days. Remidex specializes in micronutrient premixes and nutraceuticals, enabling Jubilant to expand its human nutrition portfolio and strengthen its leadership in specialty chemicals.

Show more

Stay Ahead – Explore Now! Puravankara Seals Landmark Bengaluru Project With ₹13 Billion GDV

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement